Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Jin F, Wang HL. Reply to: Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future. Int J Infect Dis 2020;95:468. [PMID: 32194235 DOI: 10.1016/j.ijid.2020.03.028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2020] [Accepted: 03/10/2020] [Indexed: 11/21/2022] Open

For:	Jin F, Wang HL. Reply to: Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future. Int J Infect Dis 2020;95:468. [PMID: 32194235 DOI: 10.1016/j.ijid.2020.03.028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2020] [Accepted: 03/10/2020] [Indexed: 11/21/2022] Open

Number

Cited by Other Article(s)

Desoubeaux G, Lemaignen A, Ehrmann S. Reply to the reply to Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future …. Int J Infect Dis 2020;95:469-470. [PMID: 32276043 DOI: 10.1016/j.ijid.2020.04.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2020] [Accepted: 04/01/2020] [Indexed: 11/17/2022] Open